Now We Can, Now We Must: Ending Malaria

As the world observes World Malaria Day on April 25, the global community finds itself at a pivotal crossroads in the long struggle against one of humanity’s oldest and most persistent foes. This annual observance, established by the World Health Assembly in 2007 to build on the earlier Africa Malaria Day, serves as a powerful reminder of both remarkable achievements and the urgent work that remains. Malaria, caused by Plasmodium parasites transmitted through the bites of infected Anopheles mosquitoes, continues to exact a devastating toll, particularly in sub-Saharan Africa, where the vast majority of cases and deaths occur. Yet amid the sobering statistics, there is genuine cause for hope. Tools, innovations, and political momentum have never aligned more favorably, making the theme for this year’s observance—“Driven to End Malaria: Now We Can. Now We Must”—not merely aspirational but a call grounded in tangible possibility.
The disease’s impact remains profound. In 2024 alone, an estimated 282 million people contracted malaria, resulting in approximately 610,000 deaths. These figures represent a slight increase from the previous year, underscoring how fragile recent gains can be when confronted by population growth, climate shifts, conflict, and funding shortfalls. Children under five and pregnant women bear the heaviest burden, with young lives cut short and maternal health compromised in regions already strained by poverty and limited healthcare access. Beyond the immediate human suffering, malaria perpetuates cycles of economic hardship. Families lose productive days to illness, children miss school, and entire communities face diminished opportunities for development. In high-burden countries like Nigeria, the Democratic Republic of the Congo, Uganda, and others that together account for the majority of global cases, the disease saps national resources and hinders broader progress toward sustainable development goals.
Yet the narrative is not one of unrelenting defeat. Since the turn of the millennium, concerted international efforts have averted an astonishing 2.3 billion cases and 14 million deaths. In 2024 specifically, more than 170 million cases and one million deaths were prevented through scaled-up interventions. Forty-seven countries and one territory have now been certified malaria-free by the World Health Organization, with several others maintaining zero indigenous cases for multiple years. The Greater Mekong Subregion has demonstrated that even in areas plagued by drug resistance, cases can plummet by nearly 90 percent through targeted strategies. These successes stem from a combination of proven tools: insecticide-treated bed nets, indoor residual spraying, rapid diagnostic tests, and artemisinin-based combination therapies. Seasonal malaria chemoprevention has reached tens of millions of children in vulnerable areas, while newer approaches, including vaccines, are beginning to take hold.
The first malaria vaccine, recommended by WHO, has begun deployment in several African nations, offering a new layer of protection for young children. Second-generation vaccines and improved formulations are in the pipeline, promising broader efficacy and easier distribution. Meanwhile, next-generation bed nets incorporating additional insecticides or synergists are countering emerging resistance in mosquito populations. These innovations reflect decades of scientific investment and collaboration among governments, research institutions, pharmaceutical companies, and global health bodies like the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Roll Back Malaria Partnership, and UNICEF. National programs, often led by dedicated health workers in remote communities, have driven much of this change, proving that locally tailored responses yield the strongest results.
Nevertheless, challenges threaten to erode these hard-won advances. Insecticide resistance has spread to vectors in numerous countries, reducing the effectiveness of standard nets and sprays. Anopheles stephensi, an urban-adapted mosquito species resistant to multiple insecticides, is expanding its footprint across Africa, complicating control in cities where traditional rural-focused strategies may fall short. Antimalarial drug resistance, once largely confined to parts of Southeast Asia, is gaining ground in Africa, raising alarms about treatment failures. Diagnostic tests face issues from gene deletions in parasites that render some rapid tests unreliable. Climate change exacerbates the problem by altering rainfall patterns and temperature zones, potentially expanding suitable habitats for mosquitoes into new territories. Conflict and humanitarian crises disrupt supply chains, displace populations, and limit access to services, while chronic underfunding leaves gaps in surveillance and response.
Funding remains a critical bottleneck. Despite calls for increased investment, resources have not kept pace with needs or population growth in endemic areas. The Global Technical Strategy for Malaria aims for substantial reductions by 2030, yet current trajectories fall short. This shortfall is not due to a lack of knowledge about what works but rather insufficient commitment to deploying those solutions at scale everywhere they are required. In many places, coverage of preventive measures hovers below optimal levels, and weak health systems struggle to deliver timely diagnosis and treatment. Socioeconomic inequities compound these issues; the poorest and most marginalized communities often face the highest risks yet receive the least protection.
Addressing these obstacles demands a multifaceted approach. Strengthening health systems through training, infrastructure, and integration of malaria services with other primary care needs is essential. Community engagement must lie at the heart of efforts, empowering local leaders, volunteers, and households to own prevention and reporting. Surveillance systems powered by data analytics and digital tools can enable rapid response to outbreaks and resistance. Research and development must accelerate, focusing on new drugs, vaccines, gene-drive technologies for mosquitoes, and environmentally sustainable vector control methods. International partnerships should prioritize equitable access, ensuring that innovations reach those who need them most without delay.
The economic case for intensified action is compelling. Every dollar invested in malaria control generates significant returns through improved productivity, reduced healthcare costs, and stronger societies. Countries that have eliminated the disease, from those in the Americas to parts of Asia and the Middle East, demonstrate the transformative power of sustained commitment. Their experiences offer blueprints adaptable to high-burden settings, emphasizing strong political leadership, cross-border collaboration, and continuous innovation. Regional initiatives, such as those targeting the Sahel or the Horn of Africa, show how shared challenges can foster collective solutions.
On this World Malaria Day, the message is clear: the tools and knowledge exist to dramatically curtail malaria’s impact and, ultimately, consign it to history. Progress in recent decades proves that elimination is achievable even in complex environments. What is required now is the will to act decisively. Governments must prioritize malaria in national budgets and policies. Donors and multilateral institutions should increase and sustain funding. The private sector can contribute through research, supply chain improvements, and corporate responsibility programs. Individuals everywhere—from students and educators to businesses and faith communities—can raise awareness, support advocacy, and participate in local prevention drives.
The theme “Driven to End Malaria: Now We Can. Now We Must” captures this moment perfectly. It acknowledges the unprecedented opportunity before us while issuing an imperative rooted in moral responsibility. Every life lost to a preventable and treatable disease represents a failure of collective imagination and resolve. Conversely, every child protected, every family spared grief, and every community freed from malaria’s shadow represents a victory for human ingenuity and solidarity. As climate pressures mount and biological threats evolve, complacency is not an option. The coming years will test whether the global community can translate awareness into accelerated action.
Looking ahead, the path to a malaria-free world will not be linear or without setbacks. Yet history shows that diseases once deemed unconquerable—smallpox being the prime example—can be defeated through perseverance. Malaria’s end will require similar dedication: integrating new technologies with time-tested methods, adapting to local contexts, and maintaining vigilance even as cases decline. It will demand addressing underlying determinants like poverty, education, and environmental stewardship. Above all, it will hinge on unity across borders, sectors, and generations.
As communities mark World Malaria Day with events, campaigns, and reflections, let the occasion renew commitment. Let it inspire policymakers to allocate resources wisely, scientists to push boundaries of discovery, and citizens to demand accountability. The suffering caused by malaria is immense, but so too is the potential for change. With determination, investment, and collaboration, the vision of ending this ancient scourge can become reality within our lifetime. The moment is now. The responsibility is ours. The time to act decisively has arrived, ensuring healthier futures for millions who have waited far too long.